maraviroc

Generic: maraviroc

Labeler: a2a integrated pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name maraviroc
Generic Name maraviroc
Labeler a2a integrated pharmaceuticals
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

maraviroc 150 mg/1

Manufacturer
A2A Integrated Pharmaceuticals

Identifiers & Regulatory

Product NDC 73141-024
Product ID 73141-024_33a02559-b292-1860-e063-6394a90a8868
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA217114
Listing Expiration 2026-12-31
Marketing Start 2024-05-16

Pharmacologic Class

Established (EPC)
ccr5 co-receptor antagonist [epc]
Mechanism of Action
chemokine co-receptor 5 antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 73141024
Hyphenated Format 73141-024

Supplemental Identifiers

RxCUI
728223 728225
UPC
0373141024021 0373141025028
UNII
MD6P741W8A
NUI
N0000175572 N0000175445

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name maraviroc (source: ndc)
Generic Name maraviroc (source: ndc)
Application Number ANDA217114 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 60 TABLET, FILM COATED in 1 BOTTLE (73141-024-02)
source: ndc

Packages (1)

73141-024-02 60 TABLET, FILM COATED in 1 BOTTLE (73141-024-02)

Ingredients (1)

maraviroc (150 mg/1)

Linked Drug Pages (1)

Maraviroc ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "33a02559-b292-1860-e063-6394a90a8868", "openfda": {"nui": ["N0000175572", "N0000175445"], "upc": ["0373141024021", "0373141025028"], "unii": ["MD6P741W8A"], "rxcui": ["728223", "728225"], "spl_set_id": ["2a16417d-a3b8-483b-9dfe-d5263cc16538"], "pharm_class_epc": ["CCR5 Co-receptor Antagonist [EPC]"], "pharm_class_moa": ["Chemokine Co-receptor 5 Antagonists [MoA]"], "manufacturer_name": ["A2A Integrated Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (73141-024-02)", "package_ndc": "73141-024-02", "marketing_start_date": "20240516"}], "brand_name": "Maraviroc", "product_id": "73141-024_33a02559-b292-1860-e063-6394a90a8868", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["CCR5 Co-receptor Antagonist [EPC]", "Chemokine Co-receptor 5 Antagonists [MoA]"], "product_ndc": "73141-024", "generic_name": "Maraviroc", "labeler_name": "A2A Integrated Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Maraviroc", "active_ingredients": [{"name": "MARAVIROC", "strength": "150 mg/1"}], "application_number": "ANDA217114", "marketing_category": "ANDA", "marketing_start_date": "20240516", "listing_expiration_date": "20261231"}